TABLE V.
Successful capture of patient-reported outcomes, by study time point
| Assessment | Patients whose assessment data were captured at ... | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Baseline (n=21) | Week 2 (n=21) | Week 5 (n=20) | Month 1 (n=19) | Month 3 (n=19) | ||||||
|
|
|
|
|
|
||||||
| (n) | (%) | (n) | (%) | (n) | (%) | (n) | (%) | (n) | (%) | |
| EQ-5D-5La | 21 | 100 | NA | 15 | 75 | 14 | 73.7 | 15 | 78.9 | |
| Functional Assessment of Cancer Therapyb module | ||||||||||
| Enteral Feedingc | NA | NA | 13 | 92.9 | 14 | 87.5 | 3 | 75 | ||
| Head and Neck Cancer | 21 | 100 | NA | NA | NA | 15 | 78.9 | |||
| M.D. Anderson Dysphagia Inventory | 21 | 100 | NA | NA | NA | 15 | 78.9 | |||
| Swallow Quality of Care | NA | NA | 17 | 85 | 14 | 73.7 | 15 | 78.9 | ||
| Patient Self-Administered Financial Expenditure | NA | 20 | 95.2 | 17 | 85 | 15 | 78.9 | 15 | 78.9 | |
a
EuroQol Research Foundation, Rotterdam, Netherlands.
b
FACIT.org, Elmhurst, IL. U.S.A.
c
Applicable only to patients with a feeding tube in situ (14 in week 5, 16 in month 1, 4 in month 3).
NA = not available.